Therapeutic combinations and compositions for the treatment of inflammatory bowel disease

G. Dijkstra (Inventor), Klaas Nico Faber (Inventor), Hermanus Jozef Martinus Harmsen (Inventor), Robert Steinert (Inventor), Wilbert Sybesma (Inventor), Araksya Topchyan (Inventor)

Research output: Patent

16 Downloads (Pure)

Abstract

The present invention relates to pharmaceutical combinations of at least one thiopurine and/or at least a pharmaceutically acceptable salt and/or at least one prodrug thereof and riboflavin to treat patients suffering from inflammatory bowel disease (IBD) or other inflammatory conditions. This invention also relates to additive and/or combinations of at least one thiopurine and riboflavin. This invention is also related to a method for the treatment or prophylaxis of IBD or other inflammatory conditions, which method comprises administering a therapeutically effective amount of thiopurine and riboflavin.
Original languageEnglish
Patent numberWO2020161088
Priority date04/02/2019
Filing date04/02/2020
Publication statusPublished - 13-Aug-2020

Cite this